MeiraGTx Holdings plc Ordinary Shares (MGTX) Dividend History

MeiraGTx Holdings plc is a clinical-stage gene therapy company focused on developing treatments for rare and serious diseases. Based in the UK, the company specializes in creating advanced gene therapy products using proprietary platforms to deliver potentially curative therapies for conditions such as neurological, ophthalmic, and infectious diseases.

450 East 29th Street, New York, NY, 10016
Phone: (646) 490-2965
Website: https://www.meiragtx.com

Dividend History

MeiraGTx Holdings plc Ordinary Shares currently does not pay dividends

Company News

Coave Therapeutics Establishes New Scientific Advisory Board to Accelerate Innovation in Genetic Medicines for Eye and CNS Diseases

Coave Therapeutics, a company pioneering genetic medicines, has established a new Scientific Advisory Board (SAB) with renowned experts in AAV vector biology, gene therapy for ophthalmology and CNS diseases, and extra-hepatic gene delivery. The SAB will provide strategic guidance to support Coave's R&D initiatives and the development of its ALIGATER platform.

GlobeNewswire Inc.

Featured Companies: RGNX
Parkinson’s Disease Therapeutic Domain Projected to See Transformational Growth Across the 7MM During the Study Period (2020–2034) | DelveInsight

The Parkinson's disease market is expected to grow significantly due to the introduction of emerging therapies, advancements in treatment options, and a rising prevalence of the condition.

GlobeNewswire Inc.

Featured Companies: ACAD AMRX LLY
2025 Market Prospects of Adeno-Associated Virus Vectors in Gene Therapy Pipeline: 200 Pipeline Drugs and the Strategic Workings of 180+ Companies

The report provides a comprehensive analysis of the Adeno-Associated Virus (AAV) Vectors in Gene Therapy pipeline, highlighting the potential of this technology to revolutionize the treatment of genetic disorders. It examines the challenges in scalable production and safety, as well as the industry's focus on optimizing vectors for improved safety, specificity, and efficiency.

GlobeNewswire Inc.

Featured Companies: ADVM BIIB FDMT JNJ PASG RARE RCKT RGNX SRPT TNYA
CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue Estimates

CRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of 12.27% and 93.94%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research

Featured Companies: CRSP
MeiraGTx to Participate in Upcoming Investor Conferences

LONDON and NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., President and Chief Executive Officer, will participate in the following investor conferences:

GlobeNewswire Inc.

Dividend data last updated 06/07/2025 15:14:20 UTC